Table 2 Prevalence of molecular markers associated with P. falciparum resistance to SP in IPTi intervention and non-intervention zone in Kolokani at baseline in May 2007.
No IPTi | IPTi | p | |||
|---|---|---|---|---|---|
Molecular Markers | n | Prevalence | n | Prevalence | |
DHPS 437 | 333 | 20.1% | 315 | 17.5% | 0.39 |
DHPS 540 | 265 | 0.4% | 313 | 1.6% | 0.22 |
DHFR 51 | 209 | 35.4% | 216 | 38.4% | 0.52 |
DHFR 59 | 220 | 48.2% | 206 | 47.6% | 0.90 |
DHFR 108 | 223 | 43.0% | 242 | 38.0% | 0.27 |
Triple DHFR mutation | 179 | 34.6% | 184 | 35.8% | 0.81 |
Quadruple mutation | 161 | 8.1% | 174 | 10.3% | 0.47 |